Sacituzumab tirumotecan

5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Sacituzumab tirumotecan
Treatment and conditionWhere it standsTrials
Sacituzumab tirumotecan for carcinoma, transitional cellPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Sacituzumab tirumotecan for endometrial neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Sacituzumab tirumotecan for neoplasm metastasisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Sacituzumab tirumotecan for squamous cell carcinoma of head and neckPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Sacituzumab tirumotecan for uterine cervical neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1